Cite
MLA Citation
Zhifei Zhao et al.. “A phase II clinical study of combining FOLFIRI and bevacizumab plus erlotinib in 2nd-line chemotherapy for patients with metastatic colorectal cancer.” Medicine, vol. 96, no. 30, 2017, p. . http://access.bl.uk/ark:/81055/vdc_100049352461.0x000031